You are here

insulin

Eli Lilly settles insulin suit for $13.5 million, agrees to keep price cap

Washington Post, DC

Tue, 05/30/23 - 09:25 pm

What you need to know about pharma, PBM execs testifying on insulin prices

Medical Marketing and Media

Wed, 05/10/23 - 11:15 pm

What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take

Fierce Pharma

Fri, 04/21/23 - 10:22 am

Price cuts lead to feel-good effects for pharma industry

Medical Marketing and Media

Mon, 04/17/23 - 11:42 am

pharma industry

Bernie Sanders weighs Senate hearing for largest insulin makers

Seeking Alpha

Thu, 04/13/23 - 11:53 am

California takes another step forward in its insulin production with $50M investment

Endpoints

Mon, 03/20/23 - 04:37 pm

Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs

Endpoints

Thu, 03/16/23 - 09:16 pm

Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly

BioSpace

Wed, 03/15/23 - 10:06 am

Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly

Forbes

Tue, 03/14/23 - 11:27 am

Why does insulin cost so much? Big Pharma isn’t the only player driving prices

Medical Marketing and Media

Thu, 03/9/23 - 11:22 am

Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices

Fierce Pharma

Sun, 03/5/23 - 03:26 pm

Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance

CNBC

Wed, 03/1/23 - 10:10 am

Eli Lilly strikes 2nd deal to boost affordable insulin access, this time in Bangladesh

Fierce Pharma

Mon, 02/13/23 - 10:21 am

Biden to push for universal insulin price cap in State of the Union

Politico

Tue, 02/7/23 - 06:53 pm

California is latest state to sue drug companies over high insulin prices

Marketwatch

Thu, 01/12/23 - 09:17 pm

Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%

Fierce Biotech

Thu, 01/12/23 - 10:39 am

type 2 diabetes

clinical trials

The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars

Drug Channels

Tue, 01/10/23 - 10:44 am

Express Scripts

Mark Cuban’s next act on drug costs: Tackling insulin

NBC News

Thu, 12/22/22 - 11:02 am

Mark Cuban Cost Plus Drugs

Medtronic begins U.S. launch of 7-day insulin infusion set

Fierce Biotech

Thu, 11/17/22 - 11:40 pm

insulin infusion device

Lilly wins FDA approval for second interchangeable insulin biosimilar

Endpoints

Thu, 11/17/22 - 11:27 pm

Pages